Vicor Technologies, Inc. (OTCBB: VCRT) is in the crucial
transformative stage for a biotechnology company on the verge of becoming
a viable commercial enterprise.  While their rollout in civilian
medical care is underway — I do NOT want to fail to point out
the enormous potential of VCRT’s relationship with the United States
Military.

The PD2i VS™ (Vital Sign), is in clinical trials under a
collaborative effort with the U.S. Army Institute for Surgical Research ( href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=654&L=1264&F=H">http://www.usaisr.amedd.army.mil/),
risk stratifies combat and civilian trauma victims. The PD2i CA™
(Cardiac Analyzer), in multiple clinical trials, identifies patients at
risk of sudden cardiac death.

I believe when we get these results VCRT will see an incredible
upswing.

Pre-Hospital and Hospital Markets

The PD2i VS™ is expected to be rolled out initially with the U.S.
Army and several international armed forces. Ultimately, the
Company’s goal is to license the technology for inclusion in
existing vital sign monitors for pre-hospital and hospital use and combat
care.

Inclusion in vital sign monitors will not preclude the development of
the Company’s own hardware in a size permitting easy battlefield
transport by combat care providers.

PD2i-VS™ Tested by U.S. Army Institute of Surgical Research
(USAISR)

Determined to minimize mortality rate of battlefield casualties, the
U.S. Army Institute of Surgical Research has been working with
Vicor’s PD2i-VS system through a research collaboration and has
tested it against the best methodologies currently src="http://stockguru.com/lt/VCRT/triage.bmp" height="237" width="288"
/>available. In extensive real-world testing involving several studies
with data provided by the USAISR, the PD2i-VS™ has proven to be more
predictive than all other compared technologies.

In Vicor’s most recent study with Army provided data, the
PD2i-VS™ examined 325 civilian trauma injury victims, twenty of whom
would later die of their injuries. Incredibly, the PD2i-VS™
correctly identified all twenty.

Even more importantly, of the twenty who died, conventional trauma
triaging techniques had selected only six for lifesaving intervention in
the field.

This suggests both that current trauma triage methods are woefully
inadequate, and that the PD2i-VS™ is poised to make an extraordinary
contribution to combat and trauma survival in the near future.

The very low PD2i™ values demonstrated in the chart at above
right signify imminent risk of “crashing”, revealing dire need
of aggressive medical intervention.

The Studies, Presentations and Collaborations between VCRT and the
United States Army is SIGNIFICANT:

Collaborative Studies Continue to Show the PD2i™ Nonlinear
Algorithm Enables Accurate Triage of the Seriously Wounded

Testing of the PD2i VS™ by the U.S. Army is continuing under the
Company’s collaborative agreement. In the completed study of 325
civilian trauma patients, researchers found that analysis of complex heart
rate complexity using the PD2i™ nonlinear algorithm and software
identifies trauma patients with good sensitivity (low percentage of false
negatives) and that results are similar using both “raw” or
“clean” electrocardiograms (“EKG’s”). This
latter point is especially important considering the real world – on
the battlefield or in civilian trauma settings – in which EKG data
is collected. This data for the PD2i VS™ will be used to file a
510(k) to establish a claim for a more accurate triaging of trauma
patients.

Additionally, Vicor has completed the programming necessary for the
PD2i VS™ to operate as a continuous vital sign monitor. In this mode,
the PD2i VS™ provides an initial PD2i™ result within three
minutes of collected data and then an updated status every minute
thereafter. Each result is accompanied by an audible tone, and a green,
yellow, or red light to indicate the patient’s change in status and
alert the emergency response team of a need for aggressive and immediate
lifesaving intervention. Vicor is completing the modification of the R-R
detector in the Company’s software to improve its already high
sensitivity and accuracy. (The accuracy of the time intervals between each
heart beat “the R-R interval” is critical to the calculation of
a PD2i™ value.)

The enhanced version of the continuous PD2i VS™, together with
the improved RR detector should enable the USAISR to utilize the
Company’s technology in an important prospective human trial.

Presentations Associated with USAISR

Andriy Batchinsky, MD, a USAISR researcher, presented findings from a
study of Vicor’s PD2i VS™ at the American Heart
Association’s Resuscitation Science Symposium 2009 (November 14-15,
2009). Dr. Batchinsky presented “Does Heart-Rate Complexity Analysis
Work in the Real World? Changes in the Point Correlation Dimension of
Heart Rate during Prehospital Lifesaving Interventions.”

This was the first presentation at a major scientific conference
featuring Vicor’s proprietary PD2i™ nonlinear algorithm. The
objective of “Does Heart-Rate Complexity Analysis Work in the Real
World?” was to evaluate the ability of the PD2i VS™ to
distinguish trauma patients receiving lifesaving interventions from those
who did not based on analysis of EKGs from 325 pre-hospital trauma
patients. The PD2i™ nonlinear algorithm value was calculated on both
unedited (raw) and on manually verified, noise-and ectopy-free (clean) EKG
sections. In conclusion, researchers found that analysis of heart rate
complexity using the PD2i™ nonlinear algorithm and software
identifies trauma patients with good sensitivity (low percentage of false
negatives) and that results are similar using either “raw” or
“clean” EKGs. Additional studies of automated trauma triage
using the PD2i VS™ are planned

Additionally, Dr. Batchinsky made the following presentations of the
USAISR’s continuing studies of the PD2i VS™:

“Are We Listening to Music or Noise? Use of the Lyapunov
Exponent for Comprehensive Assessment of Heart Rate Complexity during
Hemorrhage in Sedated Conscious Miniature Swine” 8th International
Conference on Complexity in Acute Illness – August 28-30, 2009
– Palo Alto, CA

“Complexity in Animal Models” and “Continuous
Complexity Analysis and Remote Battlefield Triage” International
Experts of Complexity and Variability at the Bedside Round Table –
August 24-25, 2009 – Wakefield, CA

“Does Heart Rate Complexity Add to Traditional Vital Signs for
Trauma Patient Triage?” ATACCC 2009 Conference – August 10-12,
2009 – St. Petersburg Beach, FL

“Toward Automated Detection of Life-threatening Injury Using
Comprehensive Assessment of the Electrocardiogram” Smart Monitoring
2009 Conference – August 9, 2009 – St. Petersburg Beach,
FL

Journal of Critical Care

Exploration of Heart-Rate Complexity to Determine the Need for
Lifesaving Intervention in Combat Casualties was published in the June
2008 Journal of Critical Care. The Company’s first collaborative
effort with the U.S. Army, this study involved combat casualties for whom
EKG files were analyzed by several competing methods. Vicor’s
PD2i™ nonlinear algorithm was the only method that correctly
identified the need for immediate life-saving intervention in all
cases.

We will keep you informed on this crucial relationship between VICOR
and the United States Military.

Vicor Technologies, Inc.
2300 NW Corporate Blvd.
Suite 123
Boca Raton, FL 33431
877.528-PD2i (7324)
href="mailto:info@vicortech.com">info@vicortech.com